The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey

Epidemiology and Infection

Volumn 142, Issue 2, 2014, Pages 239-245

  Koksal, I ^a   Yilmaz, G ^a   Aksoy, F ^a   Erensoy, S ^a   Aydin, H ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Anti CCHFV IgG antibodies; Bunyaviridae; Crimean Congo haemorrhagic fever; viral haemorrhagic fever; zoonotic diseases

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADULT; AIRBORNE INFECTION; ANIMAL; ANIMAL HUSBANDRY; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; CONTACT SENSITIVITY; CRIMEAN CONGO HEMORRHAGIC FEVER; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NAIRO VIRUS; NORMAL HUMAN; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; RURAL AREA; SEROPREVALENCE; TICK; TURKEY (REPUBLIC); ENVIRONMENT; FAMILY SIZE; HEMORRHAGIC FEVER, CRIMEAN; IMMUNOLOGY; MIDDLE AGED; NAIROVIRUS; STATISTICS AND NUMERICAL DATA; TRANSMISSION; TURKEY; VIROLOGY;

ADULT; ANIMAL HUSBANDRY; ANIMALS; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; ENVIRONMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILY CHARACTERISTICS; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TICKS; TURKEY;

EID: 84894382804     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813001155     Document Type: Article

References (32)

1. Whitehouse CA. Crimean-Congo haemorrhagic fever. Antiviral Research 2004; 64: 145-160.
2. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infectious Diseases 2006; 6: 203-214.
3. Saijo M, Morikawa S, Kurane I. Recent progress in the treatment for Crimean-Congo haemorrhagic fever and future perspectives. Future Virology 2010; 5: 801-809.
4. Sidira P, et al. Seroepidemiological study of Crimean-Congo haemorrhagic fever in Greece, 2009-2010. Clinical Microbiology and Infection 2012; 18: E16-19.
5. Vorou RM, Papavassiliou VG, Tsiodras S. Emerging zoonoses and vector-borne infections affecting humans in Europe. Epidemiology and Infection 2007; 135: 1231-1247.
6. Karti SS, et al. Crimean-Congo haemorrhagic fever in Turkey. Emerging Infectious Diseases 2004; 19: 1379-1384.
7. Gunaydin NS, et al. Crimean-Congo haemorrhagic fever cases in the eastern Black Sea Region of Turkey: demographic, geographic, climatic, and clinical characteristics. Turkish Journal of Medical Sciences 2010; 40: 829-834.
8. Yilmaz GR, et al. The epidemiology of Crimean-Congo haemorrhagic fever in Turkey, 2002-2007. International Journal of Infectious Diseases 2009; 13: 380-386.
9. Chinikar S, et al. Crimean-Congo haemorrhagic fever in Iran and neighboring countries. Journal of Clinical Virology 2010; 47: 110-114.
10. Ergonul O. Crimean-Congo haemorrhagic fever virus: new outbreaks, new discoveries. Current Opinion in Virology 2012; 2: 215-220.
11. Gergova I, Kunchev M, Kamarinchev B. Crimean-Congo haemorrhagic fever virustick survey in endemic areas in Bulgaria. Journal of Medical Virology 2012; 84: 608-614.
12. Bodur H, et al. Subclinical infections with Crimean-Congo haemorrhagic fever virus, Turkey. Emerging Infectious Diseases 2012; 18: 640-642.
13. Izadi S, et al. Crimean-Congo haemorrhagic fever in Sistan and Baluchestan Province of Iran, a case-control study on epidemiological characteristics. International Journal of Infectious Diseases 2004; 8: 299-306.
14. Humolli I, et al. Epidemiological, serological and herd immunity of Crimean-Congo haemorrhagic fever in Kosovo. Medical Archives 2010; 64: 91-93.
15. Williams RJ, et al. Crimean-congo haemorrhagic fever: a seroepidemiological and tick survey in the Sultanate of Oman. Tropical Medicine and International Health 2000; 5: 99-106.
16. Ministry of Health, Turkey. Reports of the Communicable Diseases Department [in Turkish]. Ankara (Turkey): Ministry of Health, 2007.
17. Mathiot CC, et al. Antibodies to haemorrhagic fever viruses in Madagascar populations. Transactions of the Royal Society Tropical Medicine and Hygiene 1989; 83: 407-409.
18. Serter D. Present status of arbovirus sero-epidemiology in the Aegean region of Turkey. In: Vesenjak-Hirjan J, Porterfield JS, Arslanagic E, eds. Arboviruses in the Mediterranean Countries. Stuttgart: Gustav Fischer Verlag, 1980, pp. 155-163.
19. Ergonul O, et al. Zoonotic infections among veterinarians in Turkey: Crimean-Congo haemorrhagic fever and beyond. International Journal of Infectious Diseases 2006; 10: 465-469.
20. Ergonul O, et al. The lack of Crimean-Congo haemor-rhagic fever virus antibodies in healthcare workers in an endemic region. International Journal of Infectious Diseases 2007; 11: 48-51.
21. Gunes T, et al. Crimean-Congo haemorrhagic fever virus in high-risk population, Turkey. Emerging Infectious Diseases 2009; 15: 461-464.
22. Ertugrul B, et al. The seroprevalence of Crimean-Congo haemorrhagic fever among inhabitants living in the endemic regions of Western Anatolia. Scandinavian Journal of Infectious Diseases 2012; 44: 276-281.
23. Vatansever Z, et al. Crimean-Congo haemorrhagic fever in Turkey. In: Ergonul O, Whitehouse CA, eds. Crimean-Congo Haemorrhagic Fever: A Global Perspective. Amsterdam: Springer, 2007, pp. 59-74.
24. Koksal I, et al. The efficacy of ribavirin in the treatment of Crimean-Congo haemorrhagic fever in Eastern Black Sea region in Turkey. Journal of Clinical Virology 2010; 47: 65-68.
25. Ozkurt Z, et al. Crimean-Congo haemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. Journal of Infection 2006; 52: 207-215.
26. Ergonul O, et al. The characteristics of Crimean-Congo haemorrhagic fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy. Clinical Infectious Diseases 2004; 39: 284-288.
27. Tarantola A, Ergonul E, Tattevin P. Estimates and prevention of Crimean Congo haemorrhagic fever risks for health-care workers. In: Ergonul O, Whithouse CA, eds. Crimean-Congo Haemorrhagic Fever: A Global Perspective. Amsterdam: Springer, 2007, pp. 281-294.
28. Kirdar S, Ertugrul MB. Crimean-Congo haemorrhagic fever [in Turkish]. Journal of Adnan Menderes Medical Faculty 2009; 10: 45-52.
29. Cevik MA, et al. Viral load as a predictor of outcome in Crimean-Congo haemorrhagic fever. Clinical Infectious Diseases 2007; 45: 96-100.
30. Saksida A, et al. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo haemorrhagic fever. Clinical and Vaccine Immunology 2010; 17: 1086-1093.
31. Cevik MA, et al. Clinical and laboratory features of Crimean-Congo haemorrhagic fever: predictors of fatality. International Journal of Infectious Diseases 2008; 12: 374-379.
32. Vorou R, Pierroutsakos IN, Maltezou HC. Crimean-Congo haemorrhagic fever. Current Opinion in Infectious Diseases 2007; 20: 495-500.